2024 LogiPharma Benchmarking Report: Building Resilience in Life Science Supply Chain

Market instabilities, geopolitical fragility, and stricter regulations are disrupting life science supply chains. This benchmarking survey, conducted among 100 industry leaders, reveals a critical need for resilient strategies to ensure uninterrupted access to essential medications.

To achieve resilient supply chains, leading companies are focusing on three pillars: transparency for earlier disruption detection, rigorous risk management to minimize unexpected event impact, and technology adoption for real-time data, proactive risk assessment, and enhanced quality control. Our survey highlights the urgency for life science companies to rethink their supply chain models.

The Challenge is Clear. So, how can life science companies move beyond reactive measures? Can your organization adapt and thrive in this new reality?